v3.5.0.2

Investments and Related Party Transactions (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2015
Summary of Maximum Exposure to Loss Associated with RS Cogen | The following table summarizes our maximum exposure to loss associated with RS Cogen as of December 31, 2015 and 2014.
|  | December 31, |
(In millions) |  | 2015 |  |  | 2014 |
Investment in and net advances to RS Cogen |  | $ | 9.5 |  |  | $ | 4.6 |
Supply contracts |  |  | 36.3 |  |  |  | 38.5 |
Maximum exposure to loss |  | $ | 45.8 |  |  | $ | 43.1 |
Schedule of Reconciliation of Minority Partner's Ownership, Reported as Noncontrolling Interest | A reconciliation of our minority partner’s ownership as of December 31, 2015 and 2014, reported as noncontrolling interest is set forth in the table below:
|  | Year Ended December 31, |
(In millions) |  | 2015 |  |  | 2014 |
Noncontrolling interest - beginning of period |  | $ | 107.9 |  |  | $ | 119.4 |
Net income (loss) attributable to noncontrolling interest |  |  | (20.7 | ) |  |  | 3.9 |
Other comprehensive loss attributable to noncontrolling interest |  |  | (4.0 | ) |  |  | (7.7 | )
Distribution to noncontrolling interest |  |  | (8.4 | ) |  |  | (7.7 | )
Noncontrolling interest - end of period |  | $ | 74.8 |  |  | $ | 107.9 |
Chlorovinyls [Member] |
Schedule of Related Party Balances | As of December 31, 2015, 2014 and 2013 and for each of the three years ended December 31, 2015, 2014 and 2013, our related party balances for the equity method investments in our chlorovinyls segment consisted of the following:
(In millions) |  | 2015 |  |  | 2014 |  |  | 2013 |  |  | Financial Statement Classification
Equity method investments |  | $ | 15.8 |  |  | $ | 11.0 |  |  | $ | 11.7 |  |  | Other long term assets
Receivables due from affiliates |  |  | 4.1 |  |  |  | 5.5 |  |  |  | 5.0 |  |  | Accounts receivables
Amounts due to affiliates |  |  | 0.2 |  |  |  | 0.4 |  |  |  | 1.9 |  |  | Accounts payable
Sales to affiliates |  |  | 17.1 |  |  |  | 16.9 |  |  |  | 10.8 |  |  | Sales
Equity in earnings from equity method investments |  |  | 0.5 |  |  |  | 0.6 |  |  |  | 0.8 |  |  | Cost of sales

X
- Definition Tabular disclosure of reconciliation of minority interest. + References No definition available. + Details
Name: | axll_ScheduleOfReconciliationOfMinorityInterestTableTextBlock
Namespace Prefix: | axll_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reporting entity's maximum exposure to loss as a result of its involvement with the Variable Interest Entity (VIE). + References No definition available. + Details
Name: | axll_ScheduleOfVariableInterestEntityEntityMaximumLossExposureTableTextBlock
Namespace Prefix: | axll_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=axll_ChlorovinylsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |